What is the appropriate dose of the 40 mg/mL amoxicillin/clavulanate suspension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dosing for 40 mg/mL Amoxicillin/Clavulanate Suspension

The 40 mg/mL amoxicillin/clavulanate suspension does not exist as a standard formulation - you are likely referring to either the 200 mg/28.5 mg per 5 mL (40 mg/5.7 mg per mL) or 400 mg/57 mg per 5 mL (80 mg/11.4 mg per mL) formulations, which should be dosed at 45 mg/kg/day of the amoxicillin component in 2 divided doses for standard infections, or 90 mg/kg/day in 2 divided doses (maximum 4000 mg/day) for resistant pathogens or severe infections. 1

Standard Dosing Recommendations

For Most Common Infections (Otitis Media, Sinusitis, Skin Infections)

Standard-dose regimen:

  • 45 mg/kg/day of amoxicillin component divided into 2 doses (using 14:1 ratio formulation)
  • Maximum: 2000 mg/day 2, 3

High-dose regimen (for resistant pathogens or recent antibiotic use):

  • 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses
  • Maximum: 4000 mg/day (e.g., one 2000 mg tablet twice daily) 4, 5, 6, 1

When to Use High-Dose (90 mg/kg/day)

Use the high-dose regimen in these specific situations:

  • Child has received antibiotics within the previous 30 days 6, 7
  • Child attends daycare 7
  • Child is younger than 2 years 7
  • Moderate to severe illness at presentation 7
  • Concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome) 6
  • Geographic area with >10% penicillin-nonsusceptible S. pneumoniae 8, 7
  • Coverage needed for β-lactamase-producing H. influenzae or M. catarrhalis 4, 5

Critical Formulation Warning

The different amoxicillin/clavulanate suspensions are NOT interchangeable 1:

  • 200 mg/28.5 mg per 5 mL contains 28.5 mg clavulanate per 5 mL
  • 400 mg/57 mg per 5 mL contains 57 mg clavulanate per 5 mL
  • 600 mg/42.9 mg per 5 mL contains 42.9 mg clavulanate per 5 mL

The 600 mg/42.9 mg per 5 mL formulation provides the optimal 14:1 ratio for high-dose therapy and should not be substituted with other formulations 1.

Specific Infection Dosing

Community-Acquired Pneumonia

  • Outpatient (<5 years): 90 mg/kg/day in 2 doses 4, 5
  • Outpatient (≥5 years): 90 mg/kg/day in 2 doses (max 4000 mg/day) 5

Acute Otitis Media

  • First-line (no risk factors): 45 mg/kg/day in 2 doses 6
  • With risk factors: 90 mg/kg/day with 6.4 mg/kg/day clavulanate in 2 doses 6

Acute Bacterial Sinusitis

  • Standard (≥2 years, no recent antibiotics): 45 mg/kg/day in 2 doses 7
  • High-risk or severe: 80-90 mg/kg/day with 6.4 mg/kg/day clavulanate in 2 doses 7

Skin and Soft Tissue Infections

  • Impetigo/cellulitis: 25 mg/kg/day (of amoxicillin component) in 2 divided doses 9, 2, 3
  • 875/125 mg twice daily for adults 2, 3

Administration Guidance

Timing: Administer at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 1

Duration:

  • Most infections: 10 days 4, 10, 6, 7
  • Acute bacterial sinusitis: Continue for 7 days after symptom resolution (minimum 10 days total) 7

Common Pitfalls to Avoid

  1. Do not substitute formulations - the clavulanate content varies significantly and affects both efficacy and tolerability 1

  2. Do not use standard-dose in high-risk patients - this leads to treatment failure with resistant S. pneumoniae (MIC 2-4 mcg/mL) 6, 7

  3. Do not exceed 6.4 mg/kg/day of clavulanate in children - higher doses increase diarrhea without improving efficacy 1

  4. Shake suspension well before each use - inadequate mixing leads to inconsistent dosing 1

  5. Refrigerate reconstituted suspension and discard after 10 days 1

References

Guideline

antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.